Optimization of trans-Splicing for Huntington's Disease RNA Therapy.
Optimization of trans-Splicing for Huntington's Disease RNA Therapy.
复制标题
DOI:
10.3389/fnins.2017.00544
复制
发表时间:
2017
影响因子:
4.3
通讯作者:
Mattis VB
中科院分区:
文献类型:
--
作者:
Rindt H;Tom CM;Lorson CL;Mattis VB
Huntington's disease (HD) is a devastating neurodegenerative disorder caused by a polyglutamine (polyQ) expansion in exon 1 of the Huntingtin (HTT) gene. We have previously demonstrated that spliceosome-mediated trans-splicing is a viable molecular strategy to specifically reduce and repair mutant HTT (mtHTT). Here, the targeted tethering efficacy of the pre-mRNA trans-splicing modules (PTM) in HTT was optimized. Various PTMs that targeted the 3′ end of HTT intron 1 or the intron 1 branch point were shown trans-splice into an HTT mini-gene, as well as the endogenous HTT pre-mRNA. PTMs that specifically target the endogenous intron 1 branch point increased the trans-splicing efficacy from 1–5 to 10–15%. Furthermore, lentiviral expression of PTMs in a human HD patient iPSC-derived neural culture significantly reversed two previously established polyQ-length dependent phenotypes. These results suggest that pre-mRNA repair of mtHTT could hold therapeutic benefit and it demonstrates an alternative platform to correct the mRNA product produced by the mtHTT allele in the context of HD.
登录
查看更多内容
影响因子:
16.2
作者:
DIFIGLIA, M;SAPP, E;ARONIN, N
通讯作者:
ARONIN, N
影响因子:
30.8
作者:
ANDREW, SE;GOLDBERG, YP;HAYDEN, MR
通讯作者:
HAYDEN, MR
影响因子:
4.5
作者:
Bañez-Coronel M;Porta S;Kagerbauer B;Mateu-Huertas E;Pantano L;Ferrer I;Guzmán M;Estivill X;Martí E
通讯作者:
Martí E
影响因子:
--
作者:
Arnulf, Isabelle;Nielsen, Jorgen;Durr, Alexandra
通讯作者:
Durr, Alexandra
影响因子:
1.2
作者:
Ebert, Allison D.;Shelley, Brandon C.;Svendsen, Clive N.
通讯作者:
Svendsen, Clive N.